Medical Devices & Consumables
Global Anti-thrombogenic Coatings Market Research Report 2026
- Feb 24, 26
- ID: 694790
- Pages: 119
- Figures: 112
- Views: 6
This report delivers a comprehensive overview of the global Anti-thrombogenic Coatings market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Anti-thrombogenic Coatings. The Anti-thrombogenic Coatings market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Anti-thrombogenic Coatings market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-thrombogenic Coatings manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Biointeractions
Hydromer
WL Gore & Associates
Toyobo
TekCyte
Surmodics
Corline Biomedical
Biomerics
Noanix
AST Products
jMedtech
Biosurf
Segment by Type
Active Anti-thrombogenic Coating
Inert Anti-thrombogenic Coating
Segment by Application
Cardiovascular Devices
Catheters and Cannulas
Dialysis and Extracorporeal Circuits
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anti-thrombogenic Coatings companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
The report segments the global Anti-thrombogenic Coatings market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Anti-thrombogenic Coatings manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Biointeractions
Hydromer
WL Gore & Associates
Toyobo
TekCyte
Surmodics
Corline Biomedical
Biomerics
Noanix
AST Products
jMedtech
Biosurf
Segment by Type
Active Anti-thrombogenic Coating
Inert Anti-thrombogenic Coating
Segment by Application
Cardiovascular Devices
Catheters and Cannulas
Dialysis and Extracorporeal Circuits
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Anti-thrombogenic Coatings companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-thrombogenic Coatings Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Active Anti-thrombogenic Coating
1.2.3 Inert Anti-thrombogenic Coating
1.3 Market by Application
1.3.1 Global Anti-thrombogenic Coatings Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cardiovascular Devices
1.3.3 Catheters and Cannulas
1.3.4 Dialysis and Extracorporeal Circuits
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-thrombogenic Coatings Market Perspective (2021–2032)
2.2 Global Anti-thrombogenic Coatings Growth Trends by Region
2.2.1 Global Anti-thrombogenic Coatings Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anti-thrombogenic Coatings Historic Market Size by Region (2021–2026)
2.2.3 Anti-thrombogenic Coatings Forecasted Market Size by Region (2027–2032)
2.3 Anti-thrombogenic Coatings Market Dynamics
2.3.1 Anti-thrombogenic Coatings Industry Trends
2.3.2 Anti-thrombogenic Coatings Market Drivers
2.3.3 Anti-thrombogenic Coatings Market Challenges
2.3.4 Anti-thrombogenic Coatings Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-thrombogenic Coatings Players by Revenue
3.1.1 Global Top Anti-thrombogenic Coatings Players by Revenue (2021–2026)
3.1.2 Global Anti-thrombogenic Coatings Revenue Market Share by Players (2021–2026)
3.2 Global Top Anti-thrombogenic Coatings Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anti-thrombogenic Coatings Revenue
3.4 Global Anti-thrombogenic Coatings Market Concentration Ratio
3.4.1 Global Anti-thrombogenic Coatings Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-thrombogenic Coatings Revenue in 2025
3.5 Global Key Players of Anti-thrombogenic Coatings Head Offices and Areas Served
3.6 Global Key Players of Anti-thrombogenic Coatings, Products and Applications
3.7 Global Key Players of Anti-thrombogenic Coatings, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anti-thrombogenic Coatings Breakdown Data by Type
4.1 Global Anti-thrombogenic Coatings Historic Market Size by Type (2021–2026)
4.2 Global Anti-thrombogenic Coatings Forecasted Market Size by Type (2027–2032)
5 Anti-thrombogenic Coatings Breakdown Data by Application
5.1 Global Anti-thrombogenic Coatings Historic Market Size by Application (2021–2026)
5.2 Global Anti-thrombogenic Coatings Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anti-thrombogenic Coatings Market Size (2021–2032)
6.2 North America Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anti-thrombogenic Coatings Market Size by Country (2021–2026)
6.4 North America Anti-thrombogenic Coatings Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-thrombogenic Coatings Market Size (2021–2032)
7.2 Europe Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anti-thrombogenic Coatings Market Size by Country (2021–2026)
7.4 Europe Anti-thrombogenic Coatings Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anti-thrombogenic Coatings Market Size (2021–2032)
8.2 Asia-Pacific Anti-thrombogenic Coatings Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (2021–2026)
8.4 Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anti-thrombogenic Coatings Market Size (2021–2032)
9.2 Latin America Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anti-thrombogenic Coatings Market Size by Country (2021–2026)
9.4 Latin America Anti-thrombogenic Coatings Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-thrombogenic Coatings Market Size (2021–2032)
10.2 Middle East & Africa Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (2021–2026)
10.4 Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biointeractions
11.1.1 Biointeractions Company Details
11.1.2 Biointeractions Business Overview
11.1.3 Biointeractions Anti-thrombogenic Coatings Introduction
11.1.4 Biointeractions Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.1.5 Biointeractions Recent Development
11.2 Hydromer
11.2.1 Hydromer Company Details
11.2.2 Hydromer Business Overview
11.2.3 Hydromer Anti-thrombogenic Coatings Introduction
11.2.4 Hydromer Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.2.5 Hydromer Recent Development
11.3 WL Gore & Associates
11.3.1 WL Gore & Associates Company Details
11.3.2 WL Gore & Associates Business Overview
11.3.3 WL Gore & Associates Anti-thrombogenic Coatings Introduction
11.3.4 WL Gore & Associates Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.3.5 WL Gore & Associates Recent Development
11.4 Toyobo
11.4.1 Toyobo Company Details
11.4.2 Toyobo Business Overview
11.4.3 Toyobo Anti-thrombogenic Coatings Introduction
11.4.4 Toyobo Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.4.5 Toyobo Recent Development
11.5 TekCyte
11.5.1 TekCyte Company Details
11.5.2 TekCyte Business Overview
11.5.3 TekCyte Anti-thrombogenic Coatings Introduction
11.5.4 TekCyte Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.5.5 TekCyte Recent Development
11.6 Surmodics
11.6.1 Surmodics Company Details
11.6.2 Surmodics Business Overview
11.6.3 Surmodics Anti-thrombogenic Coatings Introduction
11.6.4 Surmodics Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.6.5 Surmodics Recent Development
11.7 Corline Biomedical
11.7.1 Corline Biomedical Company Details
11.7.2 Corline Biomedical Business Overview
11.7.3 Corline Biomedical Anti-thrombogenic Coatings Introduction
11.7.4 Corline Biomedical Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.7.5 Corline Biomedical Recent Development
11.8 Biomerics
11.8.1 Biomerics Company Details
11.8.2 Biomerics Business Overview
11.8.3 Biomerics Anti-thrombogenic Coatings Introduction
11.8.4 Biomerics Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.8.5 Biomerics Recent Development
11.9 Noanix
11.9.1 Noanix Company Details
11.9.2 Noanix Business Overview
11.9.3 Noanix Anti-thrombogenic Coatings Introduction
11.9.4 Noanix Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.9.5 Noanix Recent Development
11.10 AST Products
11.10.1 AST Products Company Details
11.10.2 AST Products Business Overview
11.10.3 AST Products Anti-thrombogenic Coatings Introduction
11.10.4 AST Products Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.10.5 AST Products Recent Development
11.11 jMedtech
11.11.1 jMedtech Company Details
11.11.2 jMedtech Business Overview
11.11.3 jMedtech Anti-thrombogenic Coatings Introduction
11.11.4 jMedtech Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.11.5 jMedtech Recent Development
11.12 Biosurf
11.12.1 Biosurf Company Details
11.12.2 Biosurf Business Overview
11.12.3 Biosurf Anti-thrombogenic Coatings Introduction
11.12.4 Biosurf Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.12.5 Biosurf Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-thrombogenic Coatings Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Active Anti-thrombogenic Coating
1.2.3 Inert Anti-thrombogenic Coating
1.3 Market by Application
1.3.1 Global Anti-thrombogenic Coatings Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Cardiovascular Devices
1.3.3 Catheters and Cannulas
1.3.4 Dialysis and Extracorporeal Circuits
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-thrombogenic Coatings Market Perspective (2021–2032)
2.2 Global Anti-thrombogenic Coatings Growth Trends by Region
2.2.1 Global Anti-thrombogenic Coatings Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Anti-thrombogenic Coatings Historic Market Size by Region (2021–2026)
2.2.3 Anti-thrombogenic Coatings Forecasted Market Size by Region (2027–2032)
2.3 Anti-thrombogenic Coatings Market Dynamics
2.3.1 Anti-thrombogenic Coatings Industry Trends
2.3.2 Anti-thrombogenic Coatings Market Drivers
2.3.3 Anti-thrombogenic Coatings Market Challenges
2.3.4 Anti-thrombogenic Coatings Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-thrombogenic Coatings Players by Revenue
3.1.1 Global Top Anti-thrombogenic Coatings Players by Revenue (2021–2026)
3.1.2 Global Anti-thrombogenic Coatings Revenue Market Share by Players (2021–2026)
3.2 Global Top Anti-thrombogenic Coatings Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Anti-thrombogenic Coatings Revenue
3.4 Global Anti-thrombogenic Coatings Market Concentration Ratio
3.4.1 Global Anti-thrombogenic Coatings Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-thrombogenic Coatings Revenue in 2025
3.5 Global Key Players of Anti-thrombogenic Coatings Head Offices and Areas Served
3.6 Global Key Players of Anti-thrombogenic Coatings, Products and Applications
3.7 Global Key Players of Anti-thrombogenic Coatings, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Anti-thrombogenic Coatings Breakdown Data by Type
4.1 Global Anti-thrombogenic Coatings Historic Market Size by Type (2021–2026)
4.2 Global Anti-thrombogenic Coatings Forecasted Market Size by Type (2027–2032)
5 Anti-thrombogenic Coatings Breakdown Data by Application
5.1 Global Anti-thrombogenic Coatings Historic Market Size by Application (2021–2026)
5.2 Global Anti-thrombogenic Coatings Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Anti-thrombogenic Coatings Market Size (2021–2032)
6.2 North America Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Anti-thrombogenic Coatings Market Size by Country (2021–2026)
6.4 North America Anti-thrombogenic Coatings Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-thrombogenic Coatings Market Size (2021–2032)
7.2 Europe Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Anti-thrombogenic Coatings Market Size by Country (2021–2026)
7.4 Europe Anti-thrombogenic Coatings Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Anti-thrombogenic Coatings Market Size (2021–2032)
8.2 Asia-Pacific Anti-thrombogenic Coatings Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (2021–2026)
8.4 Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Anti-thrombogenic Coatings Market Size (2021–2032)
9.2 Latin America Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Anti-thrombogenic Coatings Market Size by Country (2021–2026)
9.4 Latin America Anti-thrombogenic Coatings Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-thrombogenic Coatings Market Size (2021–2032)
10.2 Middle East & Africa Anti-thrombogenic Coatings Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (2021–2026)
10.4 Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biointeractions
11.1.1 Biointeractions Company Details
11.1.2 Biointeractions Business Overview
11.1.3 Biointeractions Anti-thrombogenic Coatings Introduction
11.1.4 Biointeractions Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.1.5 Biointeractions Recent Development
11.2 Hydromer
11.2.1 Hydromer Company Details
11.2.2 Hydromer Business Overview
11.2.3 Hydromer Anti-thrombogenic Coatings Introduction
11.2.4 Hydromer Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.2.5 Hydromer Recent Development
11.3 WL Gore & Associates
11.3.1 WL Gore & Associates Company Details
11.3.2 WL Gore & Associates Business Overview
11.3.3 WL Gore & Associates Anti-thrombogenic Coatings Introduction
11.3.4 WL Gore & Associates Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.3.5 WL Gore & Associates Recent Development
11.4 Toyobo
11.4.1 Toyobo Company Details
11.4.2 Toyobo Business Overview
11.4.3 Toyobo Anti-thrombogenic Coatings Introduction
11.4.4 Toyobo Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.4.5 Toyobo Recent Development
11.5 TekCyte
11.5.1 TekCyte Company Details
11.5.2 TekCyte Business Overview
11.5.3 TekCyte Anti-thrombogenic Coatings Introduction
11.5.4 TekCyte Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.5.5 TekCyte Recent Development
11.6 Surmodics
11.6.1 Surmodics Company Details
11.6.2 Surmodics Business Overview
11.6.3 Surmodics Anti-thrombogenic Coatings Introduction
11.6.4 Surmodics Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.6.5 Surmodics Recent Development
11.7 Corline Biomedical
11.7.1 Corline Biomedical Company Details
11.7.2 Corline Biomedical Business Overview
11.7.3 Corline Biomedical Anti-thrombogenic Coatings Introduction
11.7.4 Corline Biomedical Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.7.5 Corline Biomedical Recent Development
11.8 Biomerics
11.8.1 Biomerics Company Details
11.8.2 Biomerics Business Overview
11.8.3 Biomerics Anti-thrombogenic Coatings Introduction
11.8.4 Biomerics Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.8.5 Biomerics Recent Development
11.9 Noanix
11.9.1 Noanix Company Details
11.9.2 Noanix Business Overview
11.9.3 Noanix Anti-thrombogenic Coatings Introduction
11.9.4 Noanix Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.9.5 Noanix Recent Development
11.10 AST Products
11.10.1 AST Products Company Details
11.10.2 AST Products Business Overview
11.10.3 AST Products Anti-thrombogenic Coatings Introduction
11.10.4 AST Products Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.10.5 AST Products Recent Development
11.11 jMedtech
11.11.1 jMedtech Company Details
11.11.2 jMedtech Business Overview
11.11.3 jMedtech Anti-thrombogenic Coatings Introduction
11.11.4 jMedtech Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.11.5 jMedtech Recent Development
11.12 Biosurf
11.12.1 Biosurf Company Details
11.12.2 Biosurf Business Overview
11.12.3 Biosurf Anti-thrombogenic Coatings Introduction
11.12.4 Biosurf Revenue in Anti-thrombogenic Coatings Business (2021–2026)
11.12.5 Biosurf Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Anti-thrombogenic Coatings Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Active Anti-thrombogenic Coating
Table 3. Key Players of Inert Anti-thrombogenic Coating
Table 4. Global Anti-thrombogenic Coatings Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Anti-thrombogenic Coatings Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Anti-thrombogenic Coatings Market Size by Region (US$ Million), 2021–2026
Table 7. Global Anti-thrombogenic Coatings Market Share by Region (2021–2026)
Table 8. Global Anti-thrombogenic Coatings Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Anti-thrombogenic Coatings Market Share by Region (2027–2032)
Table 10. Anti-thrombogenic Coatings Market Trends
Table 11. Anti-thrombogenic Coatings Market Drivers
Table 12. Anti-thrombogenic Coatings Market Challenges
Table 13. Anti-thrombogenic Coatings Market Restraints
Table 14. Global Anti-thrombogenic Coatings Revenue by Players (US$ Million), 2021–2026
Table 15. Global Anti-thrombogenic Coatings Market Share by Players (2021–2026)
Table 16. Global Top Anti-thrombogenic Coatings Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-thrombogenic Coatings Revenue, 2025
Table 17. Ranking of Global Top Anti-thrombogenic Coatings Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Anti-thrombogenic Coatings Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Anti-thrombogenic Coatings, Headquarters and Area Served
Table 20. Global Key Players of Anti-thrombogenic Coatings, Products and Applications
Table 21. Global Key Players of Anti-thrombogenic Coatings, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Anti-thrombogenic Coatings Market Size by Type (US$ Million), 2021–2026
Table 24. Global Anti-thrombogenic Coatings Revenue Market Share by Type (2021–2026)
Table 25. Global Anti-thrombogenic Coatings Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Anti-thrombogenic Coatings Revenue Market Share by Type (2027–2032)
Table 27. Global Anti-thrombogenic Coatings Market Size by Application (US$ Million), 2021–2026
Table 28. Global Anti-thrombogenic Coatings Revenue Market Share by Application (2021–2026)
Table 29. Global Anti-thrombogenic Coatings Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Anti-thrombogenic Coatings Revenue Market Share by Application (2027–2032)
Table 31. North America Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 33. North America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Anti-thrombogenic Coatings Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 46. Biointeractions Company Details
Table 47. Biointeractions Business Overview
Table 48. Biointeractions Anti-thrombogenic Coatings Product
Table 49. Biointeractions Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 50. Biointeractions Recent Development
Table 51. Hydromer Company Details
Table 52. Hydromer Business Overview
Table 53. Hydromer Anti-thrombogenic Coatings Product
Table 54. Hydromer Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 55. Hydromer Recent Development
Table 56. WL Gore & Associates Company Details
Table 57. WL Gore & Associates Business Overview
Table 58. WL Gore & Associates Anti-thrombogenic Coatings Product
Table 59. WL Gore & Associates Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 60. WL Gore & Associates Recent Development
Table 61. Toyobo Company Details
Table 62. Toyobo Business Overview
Table 63. Toyobo Anti-thrombogenic Coatings Product
Table 64. Toyobo Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 65. Toyobo Recent Development
Table 66. TekCyte Company Details
Table 67. TekCyte Business Overview
Table 68. TekCyte Anti-thrombogenic Coatings Product
Table 69. TekCyte Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 70. TekCyte Recent Development
Table 71. Surmodics Company Details
Table 72. Surmodics Business Overview
Table 73. Surmodics Anti-thrombogenic Coatings Product
Table 74. Surmodics Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 75. Surmodics Recent Development
Table 76. Corline Biomedical Company Details
Table 77. Corline Biomedical Business Overview
Table 78. Corline Biomedical Anti-thrombogenic Coatings Product
Table 79. Corline Biomedical Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 80. Corline Biomedical Recent Development
Table 81. Biomerics Company Details
Table 82. Biomerics Business Overview
Table 83. Biomerics Anti-thrombogenic Coatings Product
Table 84. Biomerics Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 85. Biomerics Recent Development
Table 86. Noanix Company Details
Table 87. Noanix Business Overview
Table 88. Noanix Anti-thrombogenic Coatings Product
Table 89. Noanix Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 90. Noanix Recent Development
Table 91. AST Products Company Details
Table 92. AST Products Business Overview
Table 93. AST Products Anti-thrombogenic Coatings Product
Table 94. AST Products Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 95. AST Products Recent Development
Table 96. jMedtech Company Details
Table 97. jMedtech Business Overview
Table 98. jMedtech Anti-thrombogenic Coatings Product
Table 99. jMedtech Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 100. jMedtech Recent Development
Table 101. Biosurf Company Details
Table 102. Biosurf Business Overview
Table 103. Biosurf Anti-thrombogenic Coatings Product
Table 104. Biosurf Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 105. Biosurf Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Anti-thrombogenic Coatings Picture
Figure 2. Global Anti-thrombogenic Coatings Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Anti-thrombogenic Coatings Market Share by Type: 2025 vs 2032
Figure 4. Active Anti-thrombogenic Coating Features
Figure 5. Inert Anti-thrombogenic Coating Features
Figure 6. Global Anti-thrombogenic Coatings Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Anti-thrombogenic Coatings Market Share by Application: 2025 vs 2032
Figure 8. Cardiovascular Devices Case Studies
Figure 9. Catheters and Cannulas Case Studies
Figure 10. Dialysis and Extracorporeal Circuits Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-thrombogenic Coatings Report Years Considered
Figure 13. Global Anti-thrombogenic Coatings Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Anti-thrombogenic Coatings Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Anti-thrombogenic Coatings Market Share by Region: 2025 vs 2032
Figure 16. Global Anti-thrombogenic Coatings Market Share by Players in 2025
Figure 17. Global Anti-thrombogenic Coatings Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Anti-thrombogenic Coatings Revenue in 2025
Figure 19. North America Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 21. United States Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 25. Germany Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Anti-thrombogenic Coatings Market Share by Region (2021–2032)
Figure 33. China Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 41. Mexico Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 45. Israel Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Biointeractions Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 49. Hydromer Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 50. WL Gore & Associates Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 51. Toyobo Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 52. TekCyte Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 53. Surmodics Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 54. Corline Biomedical Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 55. Biomerics Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 56. Noanix Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 57. AST Products Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 58. jMedtech Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 59. Biosurf Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Anti-thrombogenic Coatings Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Active Anti-thrombogenic Coating
Table 3. Key Players of Inert Anti-thrombogenic Coating
Table 4. Global Anti-thrombogenic Coatings Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Anti-thrombogenic Coatings Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Anti-thrombogenic Coatings Market Size by Region (US$ Million), 2021–2026
Table 7. Global Anti-thrombogenic Coatings Market Share by Region (2021–2026)
Table 8. Global Anti-thrombogenic Coatings Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Anti-thrombogenic Coatings Market Share by Region (2027–2032)
Table 10. Anti-thrombogenic Coatings Market Trends
Table 11. Anti-thrombogenic Coatings Market Drivers
Table 12. Anti-thrombogenic Coatings Market Challenges
Table 13. Anti-thrombogenic Coatings Market Restraints
Table 14. Global Anti-thrombogenic Coatings Revenue by Players (US$ Million), 2021–2026
Table 15. Global Anti-thrombogenic Coatings Market Share by Players (2021–2026)
Table 16. Global Top Anti-thrombogenic Coatings Players by Tier (Tier 1, Tier 2, and Tier 3), based on Anti-thrombogenic Coatings Revenue, 2025
Table 17. Ranking of Global Top Anti-thrombogenic Coatings Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Anti-thrombogenic Coatings Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Anti-thrombogenic Coatings, Headquarters and Area Served
Table 20. Global Key Players of Anti-thrombogenic Coatings, Products and Applications
Table 21. Global Key Players of Anti-thrombogenic Coatings, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Anti-thrombogenic Coatings Market Size by Type (US$ Million), 2021–2026
Table 24. Global Anti-thrombogenic Coatings Revenue Market Share by Type (2021–2026)
Table 25. Global Anti-thrombogenic Coatings Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Anti-thrombogenic Coatings Revenue Market Share by Type (2027–2032)
Table 27. Global Anti-thrombogenic Coatings Market Size by Application (US$ Million), 2021–2026
Table 28. Global Anti-thrombogenic Coatings Revenue Market Share by Application (2021–2026)
Table 29. Global Anti-thrombogenic Coatings Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Anti-thrombogenic Coatings Revenue Market Share by Application (2027–2032)
Table 31. North America Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 33. North America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Anti-thrombogenic Coatings Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Anti-thrombogenic Coatings Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Anti-thrombogenic Coatings Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Anti-thrombogenic Coatings Market Size by Country (US$ Million), 2027–2032
Table 46. Biointeractions Company Details
Table 47. Biointeractions Business Overview
Table 48. Biointeractions Anti-thrombogenic Coatings Product
Table 49. Biointeractions Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 50. Biointeractions Recent Development
Table 51. Hydromer Company Details
Table 52. Hydromer Business Overview
Table 53. Hydromer Anti-thrombogenic Coatings Product
Table 54. Hydromer Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 55. Hydromer Recent Development
Table 56. WL Gore & Associates Company Details
Table 57. WL Gore & Associates Business Overview
Table 58. WL Gore & Associates Anti-thrombogenic Coatings Product
Table 59. WL Gore & Associates Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 60. WL Gore & Associates Recent Development
Table 61. Toyobo Company Details
Table 62. Toyobo Business Overview
Table 63. Toyobo Anti-thrombogenic Coatings Product
Table 64. Toyobo Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 65. Toyobo Recent Development
Table 66. TekCyte Company Details
Table 67. TekCyte Business Overview
Table 68. TekCyte Anti-thrombogenic Coatings Product
Table 69. TekCyte Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 70. TekCyte Recent Development
Table 71. Surmodics Company Details
Table 72. Surmodics Business Overview
Table 73. Surmodics Anti-thrombogenic Coatings Product
Table 74. Surmodics Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 75. Surmodics Recent Development
Table 76. Corline Biomedical Company Details
Table 77. Corline Biomedical Business Overview
Table 78. Corline Biomedical Anti-thrombogenic Coatings Product
Table 79. Corline Biomedical Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 80. Corline Biomedical Recent Development
Table 81. Biomerics Company Details
Table 82. Biomerics Business Overview
Table 83. Biomerics Anti-thrombogenic Coatings Product
Table 84. Biomerics Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 85. Biomerics Recent Development
Table 86. Noanix Company Details
Table 87. Noanix Business Overview
Table 88. Noanix Anti-thrombogenic Coatings Product
Table 89. Noanix Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 90. Noanix Recent Development
Table 91. AST Products Company Details
Table 92. AST Products Business Overview
Table 93. AST Products Anti-thrombogenic Coatings Product
Table 94. AST Products Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 95. AST Products Recent Development
Table 96. jMedtech Company Details
Table 97. jMedtech Business Overview
Table 98. jMedtech Anti-thrombogenic Coatings Product
Table 99. jMedtech Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 100. jMedtech Recent Development
Table 101. Biosurf Company Details
Table 102. Biosurf Business Overview
Table 103. Biosurf Anti-thrombogenic Coatings Product
Table 104. Biosurf Revenue in Anti-thrombogenic Coatings Business (US$ Million), 2021–2026
Table 105. Biosurf Recent Development
Table 106. Research Programs/Design for This Report
Table 107. Key Data Information from Secondary Sources
Table 108. Key Data Information from Primary Sources
Table 109. Authors List of This Report
List of Figures
Figure 1. Anti-thrombogenic Coatings Picture
Figure 2. Global Anti-thrombogenic Coatings Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Anti-thrombogenic Coatings Market Share by Type: 2025 vs 2032
Figure 4. Active Anti-thrombogenic Coating Features
Figure 5. Inert Anti-thrombogenic Coating Features
Figure 6. Global Anti-thrombogenic Coatings Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Anti-thrombogenic Coatings Market Share by Application: 2025 vs 2032
Figure 8. Cardiovascular Devices Case Studies
Figure 9. Catheters and Cannulas Case Studies
Figure 10. Dialysis and Extracorporeal Circuits Case Studies
Figure 11. Others Case Studies
Figure 12. Anti-thrombogenic Coatings Report Years Considered
Figure 13. Global Anti-thrombogenic Coatings Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 14. Global Anti-thrombogenic Coatings Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 15. Global Anti-thrombogenic Coatings Market Share by Region: 2025 vs 2032
Figure 16. Global Anti-thrombogenic Coatings Market Share by Players in 2025
Figure 17. Global Anti-thrombogenic Coatings Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 18. The Top 10 and 5 Players Market Share by Anti-thrombogenic Coatings Revenue in 2025
Figure 19. North America Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 20. North America Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 21. United States Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Canada Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 24. Europe Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 25. Germany Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. France Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. U.K. Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Italy Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Russia Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Ireland Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 32. Asia-Pacific Anti-thrombogenic Coatings Market Share by Region (2021–2032)
Figure 33. China Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. Japan Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. South Korea Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. Southeast Asia Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. India Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Australia & New Zealand Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 40. Latin America Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 41. Mexico Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Brazil Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Middle East & Africa Anti-thrombogenic Coatings Market Share by Country (2021–2032)
Figure 45. Israel Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Saudi Arabia Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. UAE Anti-thrombogenic Coatings Market Size YoY Growth (US$ Million), 2021–2032
Figure 48. Biointeractions Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 49. Hydromer Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 50. WL Gore & Associates Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 51. Toyobo Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 52. TekCyte Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 53. Surmodics Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 54. Corline Biomedical Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 55. Biomerics Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 56. Noanix Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 57. AST Products Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 58. jMedtech Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 59. Biosurf Revenue Growth Rate in Anti-thrombogenic Coatings Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Trichosanthes Kirilowii Extract Market Research Report 2026
Feb 24, 26
Global Glass Lined Containers Market Research Report 2026
Feb 24, 26
Global Open End Wrenches Market Research Report 2026
Feb 24, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232